Immune cells convert an immunosuppressive lipid into an anticancer immunity enhancer.
March 2024. Full story at National Cancer Institute.
Immune cells convert an immunosuppressive lipid into an anticancer immunity enhancer.
March 2024. Full story at National Cancer Institute.